Cargando…

A SDHC Founder Mutation Causes Paragangliomas (PGLs) in the French Canadians: New Insights on the SDHC-Related PGL

BACKGROUND: More than 40% of patients with paragangliomas (PGLs) harbor a germline mutation of the known PGL susceptibility genes, mainly in the SDHB or SDHD genes. OBJECTIVE: The objective of the study was to characterize the genetic background of the French Canadian (FC) patients with PGLs and pro...

Descripción completa

Detalles Bibliográficos
Autores principales:	Bourdeau, Isabelle, Grunenwald, Solange, Burnichon, Nelly, Khalifa, Emmanuel, Dumas, Nadine, Binet, Marie-Claire, Nolet, Serge, Gimenez-Roqueplo, Anne-Paule
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Endocrine Society 2016
Materias:	Original Articles
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5155677/ https://www.ncbi.nlm.nih.gov/pubmed/27700540 http://dx.doi.org/10.1210/jc.2016-1665

Ejemplares similares

OR08-05 Case Series Of French Canadian Patients With Paragangliomas Carrying The c.397C>T SDHC Mutation: Insights On SDHC Phenotype And Outcomes
por: Salle, Stefanie Parisien-La, et al.
Publicado: (2023)

MON-212 Genetic Spectrum Of A Canadian Cohort Of Sporadic Pheochromocytomas And Paragangliomas: Higher Prevalence Of Germline Mutations In PGL And NGS Assay With A Multigene Panel Increases The Mutation Rate
por: Salle, Stefanie Parisien-La, et al.
Publicado: (2020)

Aberrant Splicing of SDHC in Families With Unexplained Succinate Dehydrogenase-Deficient Paragangliomas
por: De Sousa, Sunita M C, et al.
Publicado: (2020)

SAT-315 SDHC Germline Mutation Carrier with Primary Paraganglioma of the Thyroid Gland
por: Lee, Hyunju, et al.
Publicado: (2019)

Cabergoline reduces 3-methoxytyramine in a SDHC patient with metastatic paraganglioma and prolactinoma
por: Hussein, Ziad, et al.
Publicado: (2021)

Mutation analysis of SDHB and SDHC: novel germline mutations in sporadic head and neck paraganglioma and familial paraganglioma and/or pheochromocytoma
por: Bayley, Jean-Pierre, et al.
Publicado: (2006)

Identification of eight novel SDHB, SDHC, SDHD germline variants in Danish pheochromocytoma/paraganglioma patients
por: Bennedbæk, Marc, et al.
Publicado: (2016)

A Unique Case of Metastatic, Functional, Hereditary Paraganglioma Associated With anSDHC Germline Mutation
por: Ong, Raquel Kristin S, et al.
Publicado: (2018)

SDHC methylation in gastrointestinal stromal tumors (GIST): a case report
por: Urbini, Milena, et al.
Publicado: (2015)

A minimal sequon sufficient for O-linked glycosylation by the versatile oligosaccharyltransferase PglS
por: Knoot, Cory J, et al.
Publicado: (2021)

Systemic mastocytosis, in the context of a deleterious germline SDHC variant, treated with ripretinib
por: Saheb Kashaf, Sara, et al.
Publicado: (2023)

SDHC epi-mutation testing in gastrointestinal stromal tumours and related tumours in clinical practice
por: Casey, Ruth T., et al.
Publicado: (2019)

Tumour risks and genotype–phenotype correlations associated with germline variants in succinate dehydrogenase subunit genes SDHB, SDHC and SDHD
por: Andrews, Katrina A, et al.
Publicado: (2018)

Epithelial to mesenchymal transition (EMT) is associated with attenuation of succinate dehydrogenase (SDH) in breast cancer through reduced expression of SDHC
por: Røsland, Gro V., et al.
Publicado: (2019)

Pheochromocytoma (PHEO) and Paraganglioma (PGL)
por: Pacak, Karel, et al.
Publicado: (2019)

Correction: Tumour risks and genotype-phenotype correlations associated with germline variants in the succinate dehydrogenase subunit genes SDHB, SDHC, and SDHD
Publicado: (2019)

Identity by Descent Mapping of Founder Mutations in Cancer Using High-Resolution Tumor SNP Data
por: Letouzé, Eric, et al.
Publicado: (2012)

Pheochromocytomas and secreting paragangliomas
por: Plouin, Pierre-François, et al.
Publicado: (2006)

Update on the genetics of paragangliomas
por: Gimenez-Roqueplo, Anne-Paule, et al.
Publicado: (2023)

Mitochondrial Deficiencies in the Predisposition to Paraganglioma
por: Lussey-Lepoutre, Charlotte, et al.
Publicado: (2017)

Overexpression of miR‐483‐5p is confined to metastases and linked to high circulating levels in patients with metastatic pheochromocytoma/paraganglioma
por: Castro‐Vega, Luis Jaime, et al.
Publicado: (2020)

Multi-omics analysis defines core genomic alterations in pheochromocytomas and paragangliomas
por: Castro-Vega, Luis Jaime, et al.
Publicado: (2015)

Circular RNA circSDHC serves as a sponge for miR-127-3p to promote the proliferation and metastasis of renal cell carcinoma via the CDKN3/E2F1 axis
por: Cen, Junjie, et al.
Publicado: (2021)

International initiative for a curated SDHB variant database improving the diagnosis of hereditary paraganglioma and pheochromocytoma
por: Ben Aim, Laurene, et al.
Publicado: (2022)

Characteristics and genetic testing outcomes of patients with clinically suspected paraganglioma/pheochromocytoma (PGL/PCC) syndrome in Singapore
por: Ting, Kay Reen, et al.
Publicado: (2020)

Pheochromocytoma and Paraganglioma in Children and Adolescents: Experience of the French Society of Pediatric Oncology (SFCE)
por: de Tersant, Marie, et al.
Publicado: (2020)

Germline mutations in the new E1’ cryptic exon of the VHL gene in patients with tumours of von Hippel-Lindau disease spectrum or with paraganglioma
por: Buffet, Alexandre, et al.
Publicado: (2020)

Clinical and genetic features of pediatric PCCs/PGLs patients: a single-center experience in China
por: Li, Minghao, et al.
Publicado: (2020)

Identification and validation of PGLS as a metabolic target for early screening and prognostic monitoring of gastric cancer
por: Yuan, Xiaoxia, et al.
Publicado: (2021)

First case report of an adrenocortical carcinoma caused by a BRCA2 mutation
por: El Ghorayeb, Nada, et al.
Publicado: (2016)

Similar gene expression profiles of sporadic, PGL2-, and SDHD-linked paragangliomas suggest a common pathway to tumorigenesis
por: Hensen, Erik F, et al.
Publicado: (2009)

The first Dutch SDHB founder deletion in paraganglioma – pheochromocytoma patients
por: Bayley, Jean-Pierre, et al.
Publicado: (2009)

Treatment responses to antiangiogenetic therapy and chemotherapy in nonsecreting paraganglioma (PGL4) of urinary bladder with SDHB mutation: A case report
por: Stigliano, Antonio, et al.
Publicado: (2018)

Genome-wide patterns of identity-by-descent sharing in the French Canadian founder population
por: Gauvin, Héloïse, et al.
Publicado: (2014)

PglB function and glycosylation efficiency is temperature dependent when the pgl locus is integrated in the Escherichia coli chromosome
por: Terra, Vanessa S., et al.
Publicado: (2022)

Vascular Pattern Analysis for the Prediction of Clinical Behaviour in Pheochromocytomas and Paragangliomas
por: Oudijk, Lindsey, et al.
Publicado: (2015)

Somatically expressed germ-granule components, PGL-1 and PGL-3, repress programmed cell death in C. elegans
por: Al-Amin, Mohammad, et al.
Publicado: (2016)

Autophagy of germ-granule components, PGL-1 and PGL-3, contributes to DNA damage-induced germ cell apoptosis in C. elegans
por: Min, Hyemin, et al.
Publicado: (2019)

Dutch founder SDHB exon 3 deletion in patients with pheochromocytoma-paraganglioma in South Africa
por: Gordon, Debra M, et al.
Publicado: (2021)

The Warburg Effect Is Genetically Determined in Inherited Pheochromocytomas
por: Favier, Judith, et al.
Publicado: (2009)

Cannot write session to /tmp/vufind_sessions/sess_0get1h7aahoek80vdf2v7uqpa1